Hemab presents phase 2 data for sutacimig, plans phase 3 trial
Hemab Therapeutics showed good results with its drug sutacimig. The drug helps people with Glanzmann thrombasthenia, a bleeding disorder. The results were from a phase 2 trial.
5.6Significance
1 source5.0Source trust